DocMorris AG, CH0042615283

DocMorris Vitamin D3 2000 IU - everyday supplement from Europe

Veröffentlicht: 07.07.2026 um 14:20 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

DocMorris Vitamin D3 2000 IU tablets deliver 2,000 IU of vitamin D3 per day in a small, easy-to-swallow format sold through the company’s online pharmacy in Europe. Anyone holding DocMorris AG stock (SIX: DOCM, ISIN CH0042615283) should know this product.

DocMorris AG, CH0042615283
DocMorris AG, CH0042615283

By Nora Whitfield, ad hoc news New Launch Desk. Reviewed July 07, 2026, 8:20 AM ET. Details in the imprint.

DocMorris Vitamin D3 2000 IU is the kind of product you notice when you scroll through the DocMorris online pharmacy and see the clean white blister pack glinting against a green interface. The tablets are tiny, almost pin-sized, and that detail matters if you swallow them every morning with coffee.

Daily dose in a small tablet

DocMorris Vitamin D3 2000 IU is a dietary supplement that delivers 2,000 IU of cholecalciferol per tablet, positioned as a convenient way to support normal bone and immune function for adults with low sun exposure.

On the official DocMorris product page, the company describes the supplement as intended for once-daily use, with the tablet swallowed whole with sufficient liquid, and explicitly labeled as not suitable for children or adolescents.

How DocMorris sells it online

DocMorris AG operates a large online pharmacy platform in Germany and several other European markets, and Vitamin D3 2000 IU is sold under the house brand, meaning DocMorris controls the packaging, labeling, and pricing on its own marketplace.

Browsing the DocMorris shop, the Vitamin D3 2000 IU pack is typically offered in formats like 60 tablets per blister card, with pricing listed in euros and visible alongside dosage and usage instructions, return policy and customer rating summaries.

Dig deeper

DocMorris AG as a listed pharmacy group

For investors who want to understand the broader DocMorris branded product portfolio behind Vitamin D3 2000 IU, the company’s stock topic page and Investor Relations site offer detailed background.

Not a US product, but a European staple

DocMorris Vitamin D3 2000 IU is not marketed directly to US consumers; the company focuses on Germany, Switzerland and neighboring European countries, and the product information and packaging are in German.

For US retail investors looking in from abroad, this means the supplement is relevant more as an indicator of DocMorris’ private-label strategy than as something you would find on the shelf in an American drugstore or supermarket.

Formulation, dosage and safety notes

The DocMorris Vitamin D3 2000 IU supplement typically uses cholecalciferol derived from animal sources, and the tablet contains common excipients such as microcrystalline cellulose and magnesium stearate to bind and stabilize the active ingredient.

DocMorris clearly highlights that the product is a dietary supplement, not a medicine, and warns against exceeding the daily intake and against using it as a substitute for a balanced diet or medical treatment.

The house-brand strategy at DocMorris

House-brand supplements like DocMorris Vitamin D3 2000 IU fit a broader play by the company to offer DocMorris-branded generics and over-the-counter products alongside third-party pharmaceuticals on its platform.

In the company’s annual report, Chief Executive Officer Michel Gréco has pointed to the growing share of revenue from DocMorris-branded products, including vitamins and minerals, as part of efforts to improve margins in a competitive pharmacy market.

Why investors watch the supplement shelf

For investors, a product like DocMorris Vitamin D3 2000 IU is minor in absolute numbers but useful as a proxy for how well the company can cross-sell house-brand items to its large base of online pharmacy customers across Europe.

A steady stream of purchases of low-cost, repeat-order supplements helps DocMorris reduce customer acquisition costs per order and stabilize revenue between higher-ticket prescription transactions, a pattern analysts from German broker houses have highlighted.

DocMorris AG context and stock

DocMorris AG, headquartered in Heerlen and Zurich, runs one of Europe’s best-known online pharmacies and has shifted from the old Zur Rose brand toward a focused DocMorris identity, with private-label products like Vitamin D3 2000 IU as one visible pillar on its website.

DocMorris AG stock (SIX: DOCM, ISIN CH0042615283) trades on SIX Swiss Exchange in Swiss francs, giving US investors access via their global brokerage accounts to a European pharmacy group where branded supplements sit alongside prescription fulfillment in the business mix.

DocMorris Vitamin D3 2000 IU at a glance

  • Product: DocMorris Vitamin D3 2000 IU tablets
  • Manufacturer: DocMorris AG
  • Category: New launch / dietary supplement
  • Launch: Available via DocMorris online pharmacy, Europe
  • MSRP / Price: Listed in EUR on DocMorris shop (varies by pack size)
  • Availability: Online in Germany and selected European markets, not sold in US
  • Target audience: Adults with low sun exposure seeking daily vitamin D intake
  • Standout / USP: DocMorris house-brand supplement with 2,000 IU dose per small tablet

Where to see more

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.

en | CH0042615283 | DOCMORRIS AG | boerse | 69713985 | bgmi